Amrize AG AMRZ ← Back to all reports

Amrize AG

AMRZ · Materials
A ★★★★ Buy
Jul 15, 2026 · Score 86 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $50.75
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $48.50 ($47.00–$50.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $63.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+24.1%

Type A - Amrize AG (AMRZ) 20260715 Stock Analysis

📅 Amrize Key Upcoming Events

🏢 Step 1: Amrize Company Overview & Business Model

Q1-A1. What is Amrize?

Q1-A2. How Does Amrize Make Money?

Q1-A3. Amrize’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Amrize’s Competitors?

Q1-A5. Amrize Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Amrize’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Amrize Have a Durable Economic Moat?

Q2-A2. Is Amrize’s Growth Sustainable?

Q2-A3. How Does Amrize Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Amrize Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Amrize? (Margins & ROIC)

Q3-A3. What Drives Amrize’s Returns? (ROIC Breakdown)

Q3-A4. Are Amrize’s Earnings High Quality?

Q3-A5. Is Amrize’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Amrize Forensic Accounting & Dilution Review

Q4-A1. Does Amrize Have Accounting Red Flags?

Q4-A2. Is Amrize Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Amrize’s Cash Flow?

Q4-A4. Is Amrize Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Amrize Management & Shareholder Alignment

Q5-A1. Can You Trust Amrize’s Management? (Guidance Track Record)

Q5-A2. What Are Amrize Insiders Doing?

Q5-A3. Is Amrize’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Amrize Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Amrize Guidance

Q6-A2. What Is Amrize’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Amrize Catalysts & Price Triggers

Q7-A1. What Could Move Amrize Stock? (Top 3 Catalysts)

Q7-A2. Amrize’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Amrize Fairly Valued? Valuation Analysis

Q8-A1. Amrize’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Amrize vs Peers: Valuation Comparison

Q8-A3. Is Amrize Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Amrize? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. Amrize’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Amrize? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Amrize?

Q9-A2. How Sensitive Is Amrize to the Economy?

Q9-A3. Amrize Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: Amrize Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Amrize? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Amrize’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Amrize’s Heavy Exposure to the Cyclical Residential Roofing Market Its Biggest Weakness?

Q2: Can Amrize’s 18x Forward P/E Be Justified by the Infrastructure Supercycle?

Q3: Will the PB Materials Acquisition Truly Accrete Cash Flow by 2026?

Q4: How Does Amrize Plan to Navigate Cement Plant Operational Disruptions?

Q5: Are the Insider Purchases by CEO Jan Jenisch a Reliable Bottom Indicator?

Q6: Can the ASPIRE Program Deliver the Targeted 70 Basis Points of Margin Expansion?

Q7: How Vulnerable is Amrize to Prolonged High Interest Rates?

Q8: What Impact Will New Permitting Constraints (NIMBY) Have on Amrize’s Future Greenfield Expansion?

Q9: Is the 1.1x to 1.7x Net Leverage Ratio Sustainable Amid $900M CapEx Plans?

Q10: Can Amrize Overtake Martin Marietta and Vulcan Materials in Valuation Multiples?

Amrize AG (AMRZ)